1. Compared to the 50-day high, the shares are 0.74 percent below this figure.
2. The shares are 21.15 percentage points away from its 50-day moving average and 16.51 percent away from its 200-day moving average, the Winfield Review reports.
3. Among analysts covering the stock, they have a 1.7 rating, with one indicating a “strong buy” and five indicating a “strong sell.”
4. The Street’s price target totals $21.20 for Surgery Partners shares.
5. Surgery Partners shares traded at $20.25 on Feb. 11, 2017.
More articles on surgery centers:
9 joint ventures ASC in January/ February
HSS, Stamford Health partner on ASC; Expect to have 400+ ambulatory cases by year’s end
Bay Area Regional Medical Center, Medistar team up on ASC — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
